US Stocks in Motion | Eli Lilly (LLY.US) rose over 5.4%, reaching a new all-time high.

According to the Wisdom Financial APP, on Monday, Eli Lilly (LLY.US) stock price reached a historic high of $981.99. As of the time of writing, the stock has risen more than 5.4%, trading at $974.415. On the news front, Goldman Sachs stated that the agreement significantly reduces the monthly fees for drugs, successfully unlocking the previously uncertain market of millions of Medicaid and medical subsidy patients, indicating huge potential for sales growth, and maintaining a forecast of a $95 billion market size by 2030. Eli Lilly, with higher market share and oral drug early launch advantage, holds the advantage, while Novo Nordisk faces multiple growth pressures, and negotiations on Individualized Reimbursement Agreement (IRA) in 2027 may further expand its price disadvantage to 18%.